Table 1.
Aptamer | Target | Company | Development Stage |
---|---|---|---|
ARC1779 | vWF | Archemix | Phase I, II |
ARC1172 | vWF | Archemix | Phase I |
ARC183 | Thrombin | Archemix | Phase I |
NU172 | Thrombin | ARCA Biopharma, Inc. | Phase I, II |
REG1 (RB006/RB007) | Factor IXa | Regado Biosciences | Phase I, IIa, IIb |